Detection of Parvovirus B19 Nucleic Acids and Expression of Viral VP1/VP2 Antigen in Human Colon Carcinoma

Yuanfei Li; Juanhong Wang; Guoqiang Zhu; Xi Zhang; Huihong Zhai; Weiping Zhang; Wenqing Wang; Gaosheng Huang
July 2007
American Journal of Gastroenterology;Jul2007, Vol. 102 Issue 7, p1489
Academic Journal
OBJECTIVES: The aim of this study was to evaluate whether parvovirus B19, a common infectious pathogen in humans, also was involved in human colon carcinoma. METHODS: A total of 119 paraffin-embedded specimens of colon polyps, adenocarcinomas, carcinoma-adjacent tissues, and normal controls were processed for nested polymerase chain reaction (PCR), in situ hybridization (ISH), immunohistochemistry (IHC), and laser capture micro dissection detection of B19 DNA and protein. The expression of cyclo-oxygenase-2 (COX-2) in the colon- cancer cells (Lovo) transfected by inducible vector for VP1u was determined by western-blot analysis. RESULTS: B19 DNA was detected in 94.6% (35/37) of colon adenocarcinomas, 67.6% (25/37) of adjacent noncancerous tissues, 85.6% (30/35) of polyps, and 60.0% (6/10) of normal controls by nested PCR, respectively. Analysis of the microdissected material confirmed the presence of viral DNA in colonic neoplastic epithelium. ISH detected B19 DNA in 81.1% (30/37) of colon adenocarcinomas, 43.2% (16/37) of adjacent noncancerous tissues, 74.3% (26/35) of polyps, and 50.0% (5/10) of normal controls, respectively. B19 protein VP1/VP2 was found in 78.4% (29/37), 32.4% (12/37), and 57.1% (20/35) of colon adenocarcinomas, tumor-adjacent tissues, and polyps, respectively, but not in normal colons (none of 10). There were significant differences in nested PCR, ISH, and IHC between adenocarcinoma and non-neoplastic adjacent tissues, and between adenocarcinoma and normal controls. Transfection of colon-cancer cells (Lovo) by inducible vector for VP1u resulted in marked upregulation of cyclo-oxygenase-2 proteins. CONCLUSIONS: Parvovirus B19 nucleic acids commonly exist in human colon tissues and VP1/VP2 antigen is preferentially located in colon polyps and adenocarcinomas lesions. B19 viral products VP1u may induce important oncogenic pathways in colon-cancer cells.


Related Articles

  • Expression and localization of axin 2 in colorectal carcinoma and its clinical implication. Schaal, Ute; Grenz, Sandra; Merkel, Susanne; Rau, Tilman; Hadjihannas, Michel; Kremmer, Elisabeth; Chudasama, Priya; Croner, Roland; Behrens, Jürgen; Stürzl, Michael; Naschberger, Elisabeth // International Journal of Colorectal Disease;Nov2013, Vol. 28 Issue 11, p1469 

    Purpose: Aberrant activation of the Wnt/β-catenin pathway plays a major role in the development of colorectal carcinoma (CRC). Axin 2 is a key protein of this pathway and is upregulated in CRC. Here, we investigated RNA- and protein expression of axin 2 in CRC tissues at the single cell...

  • The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors. Schildgen, Verena; Malecki, Monika; Tillmann, Ramona-Liza; Brockmann, Michael; Schildgen, Oliver // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Human bocavirus is the second autonomous human parvovirus with assumed pathogenic potential. Other parvoviruses are known to persist and even integrate into the host genome, eventually contributing to the multi-step development of cancer. Human bocavirus also persists in an unknown percentage of...

  • Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Ooi, Akishi; Takehana, Takuo; Xiaoling Li; Suzuki, Shioto; Kunitomo, Kazuyoshi; Iino, Hiroshi; Fujii, Hideki; Takeda, Yasuhisa; Dobashi, Yoh // Modern Pathology;Aug2004, Vol. 17 Issue 8, p895 

    Overexpression of HER-2 and the epidermal growth factor receptor (EGFR) has been observed in many cancers, sometimes accompanied by gene amplification. To assess whether novel chemotherapies targeting these overexpressed proteins may be effective for the treatment of colorectal cancers, we...

  • EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer. Ålgars, A.; Lintunen, M.; Carpén, O.; Ristamäki, R.; Sundström, J. // British Journal of Cancer;7/4/2011, Vol. 105 Issue 2, p255 

    Background:Only 40-70% of metastatic colorectal cancers (mCRCs) with wild-type (WT) KRAS oncogene respond to anti-epidermal growth factor receptor (anti-EGFR) antibody treatment. EGFR amplification has been suggested as an additional marker to predict the response. However, improved methods for...

  • Evaluation of biodistribution and safety of adenovirus vector containing MDR1 in mice. ZhenZhen Zhao; Wei Liu; YuXi Su; Jin Zhu; GaiHuan Zheng; Qing Luo; XianQing Jin // Journal of Experimental & Clinical Cancer Research (17569966);2010, Vol. 29, p1 

    Background: The aim of this study is to examine the safety and distribution of Ad-EGFP-MDR1, an adenovirus encoding human multidurg resistance gene (human MDR1), in the mice colon carcinoma model. Methods: After bone marrow cells (BMCs) were infected with Ad-EGFP-MDR1, they were administered by...

  • Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Molinari, F.; Martin, V.; Saletti, P.; De Dosso, S.; Spitale, A.; Camponovo, A.; Bordoni, A.; Crippa, S.; Mazzucchelli, L.; Frattini, M. // British Journal of Cancer;4/7/2009, Vol. 100 Issue 7, p1087 

    Cetuximab and panitumumab efficacy in metastatic colorectal cancer (mCRC) may be influenced by EGFR gene status and/or deregulation of its downstream signalling proteins detected in primary tumour. However, metastasis might have different molecular patterns with respect to primary tumour,...

  • HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression. Seo, An Na; Kwak, Yoonjin; Kim, Duck-Woo; Kang, Sung-Bum; Choe, Gheeyoung; Kim, Woo Ho; Lee, Hye Seung // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    This study aimed at determining the incidence and clinical implications of HER2 status in primary colorectal cancer (CRC). HER2 status was investigated in two retrospective cohorts of 365 consecutive CRC patients (cohort 1) and 174 advanced CRC patients with synchronous or metachronous distant...

  • Significance of human epidermal growth factor receptor 2 expression in colorectal cancer. JINHUA TU; YINGHAO YU; WEI LIU; SHUNPING CHEN // Experimental & Therapeutic Medicine;2015, Vol. 9 Issue 1, p17 

    The aim of the present study was to evaluate the protein expression level of human epidermal growth factor receptor 2 (HER-2) using immunohistochemistry (IHC), and assess the association with clinicopathological parameters and the prognosis of patients with colorectal cancer (CRC). In addition,...

  • How should HER2 status be determined? McNeil, Caroline // JNCI: Journal of the National Cancer Institute;01/20/99, Vol. 91 Issue 2, p111 

    Presents information on the determination of HER2 status on breast tumors. Advantages and disadvantages of immunohistochemistry and fluorescent in situ hybridization (FISH); HER2 tests approved by the United States Food and Drug Administration.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics